Melatonin levels in the Alzheimer’s disease continuum: a systematic review

BACKGROUND: The search for new Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and blood biomarkers with potential pathophysiological and clinical relevance continues, as new biomarkers might lead to improved early and differential diagnosis, monitoring of disease progression and might even ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Nous, Amber, Engelborghs, Sebastiaan, Smolders, Ilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903801/
https://www.ncbi.nlm.nih.gov/pubmed/33622399
http://dx.doi.org/10.1186/s13195-021-00788-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903801/
https://www.ncbi.nlm.nih.gov/pubmed/33622399
http://dx.doi.org/10.1186/s13195-021-00788-6

Ejemplares similares